Bon Secours Cork Cancer Centre

@BonsCancerCork

Providing high-quality cancer care locally in Cork. Surgical, medical and radiation oncology care within the same building. Focused on cancer clinical trials

Bon Secours Hospital Cork bonsecours.ie/cork/departmen… Joined December 2021

95 Following 403 Followers 195 Posts

Latest posts 5

Bon Secours Cork Cancer Centre @BonsCancerCork Mar 31

🌟another milestone with the 8th patient randomised to the MK2870-010 trial 8️⃣👏 PI @conlethmurphy

💡Trial details: merckclinicaltrials.com/trial/nct06312…

@UCCCancerTrials @CanResUCC @BreakthroCancer @IrishCancerSoc @cancertrials_ie

www.merckclinicaltrials.com A Study of Sacituzumab Tirumotecan as a Single Agent and in Combination With Pembrolizumab Versus... The purpose of this study is to compare sacituzumab tirumotecan as a single agent, and in combination with pembrolizumab, versus Treatment of Physician's Choice (TPC) in participants with hormone...

Bon Secours Cork Cancer Centre @BonsCancerCork May 20, 2025

Celebrating #InternationalClinicalTrialsDay 🌍 with our incredible team and colleagues here at Bon Secours Cork Cancer Centre. “Teamwork divides the task and multiplies the success”. @cancertrials_ie

Bon Secours Cork Cancer Centre @BonsCancerCork Feb 7, 2025

2️⃣ 2nd patient randomised on the MK2870-012 trial! 🎉 Grateful for our dedicated team and courageous patients in contributing to advancing new treatment options ✨@conlethmurphy

💡trial details: merckclinicaltrials.com/trial/nct06393…

www.merckclinicaltrials.com Sacituzumab Tirumotecan Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR - Merck... This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice...

Bon Secours Cork Cancer Centre @BonsCancerCork Feb 6, 2025

1️⃣ First patient randomized in the MK2870-010 trial offering Sacituzumab Tirumotecan alone or in combination with Pembrolizumab vs. Standard treatment for unresectable locally advanced/MBC! 🎉
👏 Huge thanks to our team & brave patients for reaching this milestone

Bon Secours Cork Cancer Centre @BonsCancerCork Feb 4, 2025

Excited to share the news that our cancer centre has been officially certified by ASCO 🎉 Patient-centred care is our focus, and we’re proud to meet expert-backed oncology medical home standards. A great start to #WorldCancerDay 🌎🎗️. Thank you @ASCO @IrishCancerSoc